Successful Treatment of Corticosteroid-Refractory Hypereosinophilia With Reslizumab

J Investig Allergol Clin Immunol. 2019 Jun;29(3):241-242. doi: 10.18176/jiaci.0366.
No abstract available

Keywords: Hypereosinophilia; Reslizumab; Treatment.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • DNA-Binding Proteins / genetics
  • Dioxygenases
  • Drug Resistance
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Hypereosinophilic Syndrome / diagnosis
  • Hypereosinophilic Syndrome / drug therapy*
  • Interleukin-5 / antagonists & inhibitors
  • Male
  • Mutation, Missense / genetics
  • Proto-Oncogene Proteins / genetics
  • Treatment Outcome
  • Veterans
  • Vietnam Conflict

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Humanized
  • DNA-Binding Proteins
  • Interleukin-5
  • Proto-Oncogene Proteins
  • reslizumab
  • Dioxygenases
  • TET2 protein, human